MLANA Primary Antibody

Item Information
Catalog #
Size
Price
Description

MLANA (melan-A) is a protein-coding gene. Diseases associated with MLANA include meningeal melanocytoma, and juvenile xanthogranuloma. Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes

Product Overview
Entrez GenelD
2315
Aliases
MART1; MART-1
Clone#
2F3B7
Host / Isotype
Mouse / IgG1
Species Reactivity
Human
Immunogen
Purified recombinant fragment of human MLANA (AA: 48-118) expressed in E. Coli.
Formulation
Purified antibody in PBS with 0.05% sodium azide.
Storage
4°C; -20°C for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
ELISA
1/10000
References
1. Mol Med Rep. 2011 Sep-Oct;4(5):799-803.
2. J Cutan Pathol. 2011 Dec;38(12):954-60.
Product Image
Western Blot
Figure 1: Western blot analysis using MLANA mAb against human MLANA (AA: 48-118) recombinant protein. (Expected MW is 33.9 kDa)
Figure 1: Western blot analysis using MLANA mAb against human MLANA (AA: 48-118) recombinant protein. (Expected MW is 33.9 kDa)
Western Blot
Figure 2: Western blot analysis using MLANA mAb against HEK293 (1) and MLANA (AA: 48-118)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 2: Western blot analysis using MLANA mAb against HEK293 (1) and MLANA (AA: 48-118)-hIgGFc transfected HEK293 (2) cell lysate.
Elisa
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
For Research Use Only. Not for use in diagnostic procedures.